Ines Cilenšek
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Angiogenesis and VEGF in Cancer 3
-
- Retinal Diseases and Treatments 7
- Glaucoma and retinal disorders 2
- Co-authors
- Daniel Petrovič (24 shared papers)Mojca Globočnik Petrovič (13 shared papers)Jana Makuc (7 shared papers)Peter Kružliak (2 shared papers)Miroslav Souček (1 shared paper)Borut Peterlin (1 shared paper)Jasenka Wagner (1 shared paper)Ivana Škrlec (1 shared paper)
- Journals
- Gene (4 papers)Disease Markers (2 papers)Acta Oncologica (1 paper)BioMed Research International (1 paper)Biomedicines (1 paper)
- Partner nations
- SloveniaBosnia and HerzegovinaSlovakia
In The Last Decade
Ines Cilenšek
28 papers receiving 347 citations
Peers
Comparison fields: 5 of 58
- Ophthalmology 74
- Clinical Biochemistry 45
- Nephrology 19
- Endocrinology, Diabetes and Metabolism 44
- Geriatrics and Gerontology 8
Countries citing papers authored by Ines Cilenšek
This map shows the geographic impact of Ines Cilenšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Cilenšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Cilenšek more than expected).
Fields of papers citing papers by Ines Cilenšek
This network shows the impact of papers produced by Ines Cilenšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Cilenšek. The network helps show where Ines Cilenšek may publish in the future.
Co-authors
The 25 scholars most cited alongside Ines Cilenšek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 49 | |
| 2 | 2012 | 45 | |
| 3 | 2012 | 34 | |
| 4 | 2012 | 34 | |
| 5 | 2015 | 24 | |
| 6 | 2013 | 20 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2018 | 13 | |
| 11 | 2022 | 11 | |
| 12 | 2017 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2011 | 8 | |
| 16 | 2017 | 8 | |
| 17 | 2017 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2016 | 6 | |
| 20 | 2023 | 5 |
About Ines Cilenšek
Ines Cilenšek is a scholar working on Molecular Biology, Ophthalmology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology, having authored 29 papers that have together received 364 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (7 papers), Nitric Oxide and Endothelin Effects (4 papers), Blood Pressure and Hypertension Studies (3 papers), Hormonal Regulation and Hypertension (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Diabetes and associated disorders (2 papers), Glaucoma and retinal disorders (2 papers) and Renin-Angiotensin System Studies (2 papers). The work is most often cited by research in Ophthalmology (74 citations), Clinical Biochemistry (45 citations), Nephrology (19 citations), Endocrinology, Diabetes and Metabolism (44 citations) and Geriatrics and Gerontology (8 citations). Ines Cilenšek has collaborated with scholars based in Slovenia, Bosnia and Herzegovina and Slovakia. Frequent co-authors include Daniel Petrovič, Mojca Globočnik Petrovič, Jana Makuc, Peter Kružliak, Miroslav Souček, Borut Peterlin, Jasenka Wagner, Ivana Škrlec, Branko Zorn and Rifet Terzić. Their work appears in journals such as Gene, Disease Markers, Acta Oncologica, BioMed Research International and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.